Yantai Zhenghai Biotechnology 대차 대조표 상태

재무 상태 기준 확인 6/6

Yantai Zhenghai Biotechnology 의 총 주주 지분은 CN¥894.9M 이고 총 부채는 CN¥0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 CN¥977.4M 및 CN¥82.6M 입니다. Yantai Zhenghai Biotechnology 의 EBIT는 CN¥165.0M 이며 이자보상배율은 -11.8 입니다. CN¥609.8M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

부채 비율

CN¥0

부채

이자 보상 비율	-11.8x
현금	CN¥609.80m
주식	CN¥894.85m
총 부채	CN¥82.55m
총 자산	CN¥977.40m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Shares Not Telling The Full Story

Sep 28

Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Mar 04

재무 상태 분석

단기부채: 300653 의 단기 자산 ( CN¥708.7M )이 단기 부채( CN¥71.4M ).

장기 부채: 300653 의 단기 자산( CN¥708.7M )이 장기 부채( CN¥11.2M ).

부채 대 자본 내역 및 분석

부채 수준: 300653 부채가 없습니다.

부채 감소: 300653 5년 전에 부채가 없었습니다.

부채 범위: 300653 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: 300653 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

Yantai Zhenghai Biotechnology 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 19%

New major risk - Share price stability

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Yantai Zhenghai Biotechnology Co., Ltd.'s (SZSE:300653) Shares Not Telling The Full Story

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Now 20% overvalued

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

Price target decreased by 7.6% to CN¥30.12

Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.31 in 2Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2024 Results on Aug 06, 2024

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.30 in 1Q 2023)

Price target decreased by 10% to CN¥31.34

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Investor sentiment deteriorates as stock falls 17%

Yantai Zhenghai Biotechnology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.28 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 01, 2023

Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023

Investor sentiment deteriorates as stock falls 22%

Now 29% undervalued after recent price drop

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.93 in FY 2021)

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

Now 26% undervalued after recent price drop

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.21 in 2Q 2021)

Investor sentiment improved over the past week

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022

High number of new and inexperienced directors

First quarter 2022 earnings: EPS exceeds analyst expectations

Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021

Full year 2021 earnings: EPS exceeds analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.34 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.30 in 2Q 2020)

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 20, 2021

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.16 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.99 (vs CN¥0.89 in FY 2019)

New 90-day low: CN¥45.02

New 90-day low: CN¥49.35

New 90-day low: CN¥52.20

Investor sentiment deteriorated over the past week

New 90-day low: CN¥57.91

New 90-day low: CN¥61.00

Third quarter earnings released

New 90-day low: CN¥68.30

First half earnings released

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2020 Results on Aug 05, 2020

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기